Intellia Therapeutics, Inc. (NTLA) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
NTLA Stock Price Trajectory (2016–2026)
As of March 2, 2026, Intellia Therapeutics, Inc. (NTLA) trades at $13.78, representing a +36.6% return over the past year. The stock has delivered a -26.5% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $202.73 on June 30, 2021. From this peak, NTLA has corrected -93.2%, currently trading 13% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers ALNY (+34.9% 1Y), IONS (+144.5% 1Y), and ARWR (+234.6% 1Y), NTLA has underperformed the peer group average. Compare NTLA vs ALNY →
Historical Price Data
Showing 30 of 2,468 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 13.96 | 14.29 | 13.57 | 13.78 | 13 | -3.50% |
| 2026-02-26 | 14.09 | 14.30 | 12.70 | 14.28 | 14 | +6.41% |
| 2026-02-25 | 13.61 | 13.93 | 13.41 | 13.42 | 13 | -1.18% |
| 2026-02-24 | 13.42 | 13.84 | 13.12 | 13.58 | 13 | +3.19% |
| 2026-02-23 | 12.47 | 13.19 | 12.47 | 13.16 | 13 | +4.11% |
| 2026-02-20 | 12.79 | 12.96 | 12.52 | 12.64 | 12 | -3.07% |
| 2026-02-19 | 12.21 | 13.08 | 12.10 | 13.04 | 2.03M | +4.49% |
| 2026-02-18 | 12.10 | 12.70 | 12.00 | 12.48 | 2.51M | +5.41% |
| 2026-02-17 | 11.82 | 12.15 | 11.69 | 11.84 | 312K | -0.25% |
| 2026-02-13 | 11.54 | 12.32 | 11.54 | 11.87 | 2.63M | +2.15% |
| 2026-02-12 | 11.88 | 11.95 | 11.21 | 11.62 | 2.94M | -3.17% |
| 2026-02-11 | 11.89 | 12.04 | 11.36 | 12.00 | 3.59M | +0.76% |
| 2026-02-10 | 12.32 | 12.54 | 11.75 | 11.91 | 2.98M | -4.64% |
| 2026-02-09 | 12.00 | 12.49 | 11.76 | 12.49 | 4.01M | +1.71% |
| 2026-02-06 | 11.32 | 12.33 | 11.32 | 12.28 | 4.61M | +10.73% |
| 2026-02-05 | 11.98 | 12.20 | 10.94 | 11.09 | 5.85M | -10.28% |
| 2026-02-04 | 13.03 | 13.07 | 11.96 | 12.36 | 4.97M | -5.29% |
| 2026-02-03 | 13.14 | 13.76 | 12.51 | 13.05 | 3.61M | -0.08% |
| 2026-02-02 | 12.99 | 13.41 | 12.80 | 13.06 | 3.20M | -0.68% |
| 2026-01-30 | 13.46 | 13.97 | 12.94 | 13.15 | 5.29M | -5.40% |
| 2026-01-29 | 13.86 | 14.67 | 13.67 | 13.90 | 4.81M | +0.58% |
| 2026-01-28 | 14.97 | 15.00 | 13.59 | 13.82 | 6.19M | -6.81% |
| 2026-01-27 | 16.51 | 17.09 | 14.20 | 14.83 | 14.97M | +6.31% |
| 2026-01-26 | 14.38 | 14.70 | 13.86 | 13.95 | 6.41M | -4.65% |
| 2026-01-24 | 15.79 | 15.95 | 14.50 | 14.63 | 8.03M | 0.00% |
| 2026-01-23 | 15.81 | 15.95 | 14.50 | 14.63 | 8.09M | -7.99% |
| 2026-01-22 | 14.03 | 15.94 | 13.76 | 15.90 | 10.52M | +13.33% |
| 2026-01-21 | 12.98 | 14.49 | 12.94 | 14.03 | 9.22M | +9.35% |
| 2026-01-20 | 12.10 | 13.17 | 11.93 | 12.83 | 9.58M | +2.64% |
| 2026-01-16 | 11.88 | 12.75 | 11.70 | 12.50 | 5.75M | +5.31% |
See NTLA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NTLA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NTLA vs AGIO
See how NTLA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has NTLA stock performed recently?
NTLA returned +36.6% over the past year, beating its 5-year annualized CAGR of -26.5%. The stock trades above its 200-day moving average, confirming the uptrend.
What is NTLA's all-time high price?
Intellia Therapeutics, Inc. reached $202.73 on 2021-06-30. The 52-week high is $28.25. Current 1-year return of +36.6% places the stock closer to historical peaks.
Where can I download NTLA historical price data?
This page provides NTLA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.